Quantitative-Trait Loci Influencing Body-Mass Index Reside on Chromosomes 7 and 13: The National Heart, Lung, and Blood Institute Family Heart Study  by Feitosa, Mary F. et al.
Am. J. Hum. Genet. 70:72–82, 2002
72
Quantitative-Trait Loci Influencing Body-Mass Index Reside
on Chromosomes 7 and 13: The National Heart, Lung, and Blood
Institute Family Heart Study
Mary F. Feitosa,1 Ingrid B. Borecki,1,2 Stephen S. Rich,3 Donna K. Arnett,4 Phyliss Sholinsky,5
Richard H. Myers,6 Mark Leppert,7 and Michael A. Province1
1Division of Biostatistics and 2Department of Genetics, Washington University School of Medicine, St. Louis; 3Department of Public Health
Sciences, Wake Forest University School of Medicine, Winston-Salem, NC; 4Division of Epidemiology, School of Public Health, University of
Minnesota, Minneapolis; 5Epidemiology and Biometry Program, National Heart, Lung, and Blood Institute, National Institutes of Health,
Bethesda; 6Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston; and 7Eccles Institute for Human
Genetics, University of Utah, Salt Lake City
Obesity is a risk factor for many chronic diseases, including glucose intolerance, lipid disorders, hypertension, and
coronary heart disease. Even though the body-mass index (BMI) is a heterogeneous phenotype reflecting the amount
of fat, lean mass, and body build, several studies have provided evidence of one or two major loci contributing to
the variation in this complex trait. We sought to identify loci with potential influence on BMI in the data obtained
from National Heart, Lung, and Blood Institute Family Heart Study. Two complementary samples were studied:
(a) 1,184 subjects in 317 sibships, with 243 markers typed by the Utah Molecular Genetics Laboratory (UMGL)
and (b) 3,027 subjects distributed among 401 three-generation families, with 404 markers typed by the Mammalian
Genotyping Service (MGS). A genome scan using a variance-components–based linkage approach was performed
for each sample, as well as for the combined sample, in which the markers from each analysis were placed on a
common genetic map. There was strong evidence for linkage on chromosome 7q32.3 in each sample: the maximum
multipoint LOD scores were 4.7 ( ) at marker GATA43C11 and 3.2 ( ) at marker D7S1804,55P ! 10 Pp .00007
for the MGS and UMGL samples, respectively. The linkage result is replicated by the consistent evidence from
these two complementary subsets. Furthermore, the evidence for linkage was maintained in the combined sample,
with a LOD score of 4.9 ( ) for both markers, which map to the same location. This signal is very near55P ! 10
the published location for the leptin gene, which is the most prominent candidate gene in this region. For the
combined-sample analysis, evidence of linkage was also found on chromosome 13q14, with D13S257 (LOD score
3.2, ), and other, weaker signals (LOD scores 1.5–1.9) were found on chromosomes 1, 2, 3, 5, 6, 14,Pp .00006
and 15.
Introduction
In Western societies, the prevalence of obesity (MIM
601665) has been increasing steadily in recent years (Fle-
gal et al. 1998; Kumanyika 2001; Visscher and Seidell
2001), and it is clearly associated with significant mor-
bidity and mortality, including glucose intolerance, lipid
disorders, hypertension (MIM 145500), and coronary
heart disease (CHD). It is known that obesity-related
traits, including the body-mass index (BMI), are influ-
enced by both genetic and environmental factors (see
Bouchard et al. 1998). BMI is very easy to measure re-
liably and accurately in large epidemiological studies and
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is highly correlated with total fat mass, with the cor-
relation being ∼0.8–0.9 in adults (Borecki et al. 1991).
The majority of studies have estimated the heritability
of the BMI to be 40%–55% (see Borecki et al. 1998b;
Bouchard et al. 1998; Rice et al. 1999), but estimates
180% have been found in twin studies. The underlying
mode of inheritance is complex; however, segregation
analyses have provided evidence for a recessive major
gene that accounts for 20%–40% of the variance, with
an additional 34%–42% of the variance attributed to a
multifactorial component (e.g., Price et al. 1990; Prov-
ince et al. 1990; Moll et al. 1991). Analyses using two-
locus models in independent studies (Hasstedt et al.
1997; Borecki et al. 1998a) have revealed evidence for
two recessive loci that together account for ∼64%–68%
of the variance. Therefore, it appears that the prospects
for gene discovery are promising, even though there is
evidence that some genotypes may interact with age and
sex (Borecki et al. 1993).
The overall aim of the National Heart, Lung, and
Blood Institute Family Heart Study (FHS) is to inves-
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tigate the genetic and nongenetic determinants of CHD,
preclinical atherosclerosis, and cardiovascular risk fac-
tors. BMI is an informative and useful indicator of fat-
ness, and a high BMI has been validated as an inde-
pendent risk factor for CHD (van Itallie and Abraham
1985). We have conducted an autosomal genome scan
for BMI through use of a variance-components linkage
analysis in families participating in the FHS, to identify
regions that are likely to harbor quantitative-trait loci
(QTLs).
Material and Methods
Study Design
The FHS is a multicenter, population-based genetic
epidemiological study that includes the Framingham
Heart Study (Framingham, MA), the Utah Health Fam-
ily Tree Study (Salt Lake City, UT), and the Atheroscle-
rosis Risk in Communities Study (Minneapolis, MN and
Forsyth County, NC). Phase I of the project was based
on the characterization of family histories of CHD and
related conditions, using the age at diagnosis and the
disease status of siblings and parents. Questionnaires
were mailed to 14,592 potential probands; from this
group, a sample consisting of 2,000 randomly ascer-
tained participants and 2,000 people with a family his-
tory of CHD was selected. Family-risk scores were cal-
culated for each ascertained family, through the ratio of
observed numbers of CHD events within the family to
the numbers expected on the basis of the age and sex
of each individual. In phase II, the families of probands
were selected, including the proband, their parents, and
all siblings, spouses, and children. Both a random sample
of 588 families and a nonrandom sample of 656 families
with the highest family-risk scores were clinically ex-
amined through use of electrocardiograms, carotid ar-
tery ultrasound scans, and spirometry, as well as through
measurements of body size, blood pressure, lipids, lipo-
proteins, hemostatic factors, insulin, glucose, and rou-
tine blood chemistries. Additional biochemical and mo-
lecular markers are being studied (in phase III) on
selected participants. For additional information about
our study design, see the report by Higgins et al. (1996).
Phenotype and Adjustments
BMI was calculated as weight (in kg) divided by the
square of height (in meters) and was adjusted for co-
variates prior to linkage analysis. For the estimation of
the regression model, data from all subjects were used,
even though only two subsets, as described below, were
genotyped for the linkage analysis.
The adjustments were performed separately, by sex, in
three age ranges (25–44 years, 45–64 years, and 65
years), using cubic polynomial age and clinical center and
retaining the terms in the stepwise regression analysis that
were significant at the 5% level. Extreme outliers (BMI
13 SD from the mean) were set aside, temporarily, for the
adjustments. Phenotypes were further adjusted for the ef-
fects of age and center in the variance (heteroscedasticity),
by regressing the squared residual on the same terms as
described above. The final phenotypes were computed for
all individuals, using the best regression models (residual
from mean regression divided by the predicted score from
the variance regression) and standardizing to 0 mean and
unit variance. The resulting distribution was neither ap-
preciably skewed nor kurtotic.
Data and Genotyping
Linkage analyses were performed on the two com-
plementary samples of white subjects in the FHS, as well
as for the combined sample. The first sample included
1,184 subjects in 317 sibships, which includes all vali-
dated sib pairs with CHD and a sample of sibships se-
lected for high individual risk scores for CHD (see the
report by Higgins et al. [1996]). An additional random
sample of unrelated individuals was typed to estimate
the population allele frequencies at the marker loci
( ). A coarse genome scan was performed withNp 200
243 markers, with an average intermarker distance of
∼20 cM. The development of the markers and genotyp-
ing were performed by the UtahMolecular Genetics Lab-
oratory (UMGL); details can be found in reports by the
Utah Marker Development Group (1995) and Broman
et al. (1998).
The second sample comprised 3,027 subjects from
401 of the largest andmost-informative three-generation
pedigrees. The ascertainment of this sample focused
solely on pedigree size rather than on extreme values of
any phenotype(s). The genotypes for these subjects were
assessed by the Mammalian Genotyping Service (MGS)
and were based on analysis of 404 markers with an
average intermarker distance of ∼8.5 cM. The markers
and map used were from the Marshfield Medical Re-
search Foundation (screening set 10) (Center forMedical
Genetics Web site). Power studies were performed for
this large sample by simulation using the computer pro-
gram SEGPOWER, developed by M. Province (Borecki
et al. 1999). We determined that the data have adequate
power (180%) to detect a QTL accounting for as little
as ∼9% of the trait variability, using variance-compo-
nents linkage methods with .ap 0.05
The combined analysis was performed using subjects
from both samples. The construction of the combined
linkage map was primarily based on the existingMarsh-
field Medical Research Foundation map, with the lo-
cation of novel markers being estimated in reference to
anchor markers present on both maps. Map locations
(in cM) are based on sex-averagedmaps from theMarsh-
field Medical Research Foundation. The corresponding
cytogenetic locations were ascertained from the Genetic
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Location Database at the University of Southampton
and the HumanGenomeWorking Draft at the University
of California, Santa Cruz (Genetic Location Database
Web site; Human GenomeWorking Draft Web site). The
combined sample included a total of 3,407 subjects in
536 pedigrees (the equivalent of 4,914 sib pairs), in
which 804 subjects were part of both the MGS and
the Utah lab samples and were genotyped by both
laboratories.
To insure the integrity of the genotype data, several
quality control measures were employed. All markers
were used to estimate the degree of genetic relationship
for all pairs of individuals within a pedigree, to verify
the reported relationships. The estimated average allele
sharing over all markers was compared under sever-
al alternative hypotheses, including unrelated, parent-
offspring, half-sibling, and full-sibling relationships,
through use of the program ASPEX (Hauser et al. 1996;
Hinds and Risch 1998; available from the ASPEX ftp
site). Self-reported relationships were corrected on the
basis of the genetic data in instances when there was
significant statistical support for an alternative relation-
ship (i.e., LOD score 13). After verification of relation-
ships, further inconsistencies due to non-Mendelian in-
heritance were identified for each marker, using the
program package PEDSYS (B. Dyke; Southwest Foun-
dation for Biomedical Research Web site). Intact pedi-
grees are analyzed, which provides additional infor-
mation for the identification of misinheritances in in-
stances when key individuals are not genotyped. Pro-
vided that the reported relationships could be verified
by ASPEX, the genotypes of single individuals with an
inconsistent marker genotype were set to missing for that
marker only. If there was any ambiguity about which
subjects may have the incorrect genotype leading to the
inconsistency, then the entire nuclear family was deleted
from the analysis for that marker.
Statistical Analysis
Linkage analysis was performed using a variance-com-
ponents approach as implemented in the computer pro-
gram SEGPATH (Province et al., in press). This method
is an extension of a path-analysis model of family re-
semblance, in which correlations among familymembers
are modeled as a function of the allele sharing at a
marker locus, taking into account residual familial cor-
relations, including genetic and common environmental
effects. The proportion of alleles that are identical by
descent were estimated byMAPMAKER/SIBS (Kruglyak
and Lander 1995), using a multipoint approach. The
heritabilities due to the trait locus and to the pseudo-
polygenic component are denoted by and , respec-2 2h hg r
tively. Spouse and residual sibling correlations are also
estimated. The null hypothesis (in which the effect of
the test locus is equal to 0—i.e., ) and the alter-2h p 0g
native hypothesis (in which the effect of the test locus
is unconstrained—i.e., ) are estimated by maximumˆ 2hg
likelihood. The difference in minus twice the log like-
lihoods ( ) of the two hypotheses produces a like-2 lnL
lihood-ratio test that is asymptotically distributed as a
1/2:1/2 mixture of x2 with 1 df and a point mass at 0.
The corresponding traditional LOD scores can be cal-
culated by dividing the x2 value by . The data were2 log10
analyzed using no ascertainment correction, largely be-
cause the ascertainment was so complex that there is no
single adequate correction. In particular, the MGS sam-
ple was largely chosen on the basis of large pedigree size,
without regard to phenotype, although approximately
half of the families came from the nonrandom pool.
These families were included in the study because of a
high familial risk and occurrence of cardiovascular dis-
ease and not because the disease status of any specific
individual(s) led to the ascertainment of the families. As
a practical matter, it seemed preferable to make no ad-
justment for ascertainment rather than to employ an
inadequate—and possibly misleading—correction.
Results
The means, standard deviations, and range intervals for
age and the unadjusted BMI are given in table 1 for the
complete FHS data set, as well as for the subsets used
in the genome scan (i.e., the UMGL and MGS samples).
Age and clinical center were significant predictors of
BMI but accounted for a modest percentage (!9%) of
the phenotypic variance in BMI.
Figure 1 shows the results for the autosomal genome
scan in the combined sample, as well as in the UMGL
and MGS samples. The strongest result from this anal-
ysis was the evidence for linkage on chromosome
7q32.3 (fig. 2). The maximum LOD score occurred at
137 cM, for the UMGL and MGS samples separately,
as well as for the combined sample on the composite
chromosome 7 map. For theMGS subset, the maximum
LOD score was 4.7 ( ) at marker GATA43C11,5P ! 10
whereas, for the UMGL sample, the maximum LOD
score was 3.2 ( ) at marker D7S1804; bothPp .00007
of these markers (GATA43C11 and D7S1804) map to
the same location (7q32.3). Moreover, the combined
sample augmented the evidence of linkage, with a
slightly higher LOD score of 4.9 ( ) at the same5P ! 10
location.
In addition, evidence for linkage was also observed
on chromosome 13 (q14) with a maximum multipoint
LOD score of 3.2 ( ) at marker D13S257,Pp .00006
in the combined sample (table 2). Other weaker but
suggestive signals (LOD scores 1.5–1.9) were observed
on chromosomes 1 (markers D1S1279, GGAA5F09,
and D1S370), 2 (marker D2S1279), 3 (marker
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Table 1
Statistics for Unadjusted BMI in FHS Data and for the Combined, UMGL, and MGS Samples
SAMPLE AND
SUBSETOF SAMPLE
MALE FEMALE
No. of
Individuals MeanSD Range
No. of
Individuals MeanSD Range
Entire FHS:
Age 2,762 52.314.1 25.0–91.0 3,213 52.914.0 25.2–93.6
BMI 2,450 27.84.5 16.0–63.6 2,882 27.56.3 16.0–62.4
UMGL:
Age 634 58.111.0 25.2–80.6 663 57.210.4 25.2–88.2
BMI 568 28.14.3 18.1–46.2 601 28.96.5 16.6–51.7
MGS:
Age 1,403 53.014.0 25.2–91.0 1,610 53.913.4 25.2–89.1
BMI 1,248 28.04.6 17.9–63.6 1,445 27.36.1 16.5–55.1
Combined (UMGL  MGS):
Age 1,638 53.913.6 25.2–91.0 1,828 54.313.0 25.2–89.1
BMI 1,462 28.04.6 17.9–63.6 1,649 27.56.1 16.5–55.1
D3S2305), 5 (markers GATA62A04 and MFD154),
6 (markers D6S393 and GATA165G02), 14 (mark-
er GGAA21G11), and 15 (markers AFM248VC5,
D15S184, and GAAA1C11).
Discussion
Strong linkage evidence for a locus on chromosome
7q32.3, accounting for 28% (3%) of the variation in
BMI, was found and replicated using two complemen-
tary samples drawn from the FHS study. Although each
of the two complementary samples exhibited linkage to
the same location, through use of different marker sets,
the evidence was stronger in the combined sample, pro-
ducing a LOD score of 4.9 ( ). An obvious can-5P ! 10
didate in this region is the leptin gene (LEP [MIM
164160]), which maps to q31.33. The leptin gene has
been implicated in other studies. Evidence for linkage
between markers localized in the LEP gene region and
various anthropometric measures has been described in
Mexican Americans (Duggirala et al. 1996; Bray et al.
1999). Duggirala et al. (1996) reported a LOD score of
3.1 for linkage between a measure of extremity subcu-
taneous fat and a location !1 cM from the LEP gene,
and Bray et al. (1999) found suggestive linkage between
the LEP gene and the waist-to-hip ratio ( ).Pp .009
In addition, suggestive linkage ( ) between aPp .008
marker near the LEP gene and fat mass, measured by
whole-body dual X-ray absorptiometry, was observed in
healthy female Australian twins (Lapsys et al. 1997).
Further evidence for linkage between the LEP gene and
extreme obesity (BMI 135 kg/m2) was reported in French
sib pairs (Cle´ment et al. 1996), in white sib pairs from
the United States (BMI 140 kg/m2; Reed et al. 1996),
and in German children and adolescents (Roth et al.
1997).
Nevertheless, several genome-scan studies have de-
tected no evidence of linkage between obesity or its re-
lated traits and the LEP gene (Comuzzie et al. 1997;
Hager et al. 1998; Norman et al. 1998; Lee et al. 1999;
Mitchell et al. 1999; Ohman et al. 2000; Perola et al.
2001). This discrepancy among linkage results is not un-
usual for studies of complex phenotypes. Many factors
can affect the ability to detect trait loci, including the
population studied, the power of the sampling unit, the
method of analysis, and, especially, the effect size of the
locus. As a consequence, one might expect that a QTL
affecting a complex, quantitative trait may not be de-
tected in all studies, since the locus may have a greater
effect in some samples than in others. Therefore, the fail-
ure to detect linkage with this region in some studies does
not decrease our interest in investigating this region fur-
ther, especially in light of the corroboration from the LEP
candidate-gene studies. Furthermore, it is interesting to
note that a meta-analysis undertaken by Allison and Heo
(1998) demonstrated that, in five published studies, the
evidence for linkage to the LEP gene regionwas extremely
strong ( ).5Pp 1.5# 10
Several studies have begun to elucidate the role and
action of leptin in the regulation of body fat stores.
Leptin is an adipocyte-derived hormone encoded by the
LEP gene and has a variety of physiologic roles. It acts
as a satiety factor with a receptor located mainly in the
hypothalamus, a brain area known to be involved in
the regulation of food intake. Leptin can also affect
energy expenditure independently of food intake (see
Friedman and Halaas 1998). Therefore, it appears that
leptin is a powerful factor affecting energy balance.
Other evidence of linkage between obesity conditions
and this region close to the LEP gene has been described,
for hypertension (Cheng et al. 2000; Rice et al. 2000;
Atwood et al. 2001) and diabetes (MIM 222100) (Han-
son et al. 1998). Given the correlation between obesity
and blood pressure, and the familial clustering of hy-
Figure 1 Results of the autosomal genome scan for BMI in the combined, UMGL, and MGS samples. The X-axis represents map distance
in centimorgans.
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Figure 2 Overview of the multipoint linkage results for chromosomes 7 and 13 for BMI in the combined, UMGL, and MGS samples.
The X-axis represents map distance in centimorgans.
pertension, glucose intolerance, and dyslipidemia, as
seen in the multiple metabolic syndrome, it appears pos-
sible that the chromosome 7 locus identified by these
studies may have broadly pleiotropic effects. Further
investigation of this hypothesis is necessary.
We also report evidence for linkage on chromosome
13q (q14) with a peak LOD score of 3.2 (Pp
) for D13S257, in the combined sample. At this.00006
same chromosomal region, additional evidence for link-
age was found, by Knoblauch et al. (2000), between
D13S156 (13q21) and BMI ( ), low-density li-P ! .0001
poprotein levels ( ), high-density lipoproteinP ! .0002
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Table 2
Markers with Evidence for Linkage
Linkage Evidence
and Chromosomea Marker
Locationb
(cM)
LOD
Score P
Strong (LOD 2.0):
7:
q31.31 D7S2847 125 2.1 .00090
q31.33 GGAA6D03 128 2.4 .00040
q32.3 GATA43C11 137 4.9 .00000
q32.3 D7S1804 137 4.9 .00000
q34 D7S2560 145 3.8 .00002
q34 GATA32C12 150 2.3 .00054
13:
q14 D13S257 42 3.2 .00006
q14 GATA137C12 46 2.9 .00013
q14 GATA11C08 47 3.0 .00010
q21.33 D13S258 55 2.0 .00124
q21-22 GATA64F08 55 2.0 .00121
Weak (LOD 1.5–1.9):
1:
q24.2 D1S1679 158 1.8 .00187
q23-24 GGAA5F09 171 1.6 .00328
q24.3 D1S370 192 1.5 .00408
2:
q37.3 D2S1279 241 1.5 .00482
3:
q29 D3S2305 217 1.5 .00414
5:
q23 GATA62A04 129 1.5 .00394
q35 MFD154 183 1.8 .00202
6:
q24 D6S393 154 1.6 .00321
q24-25 GATA165G02 155 1.6 .00373
14:
q32 GGAA21G11 105 1.5 .00394
15:
q13.3 AFM248vc5 20 1.6 .00302
q13.3 D15S184 22 1.6 .00308
q14 GAAA1C11 31 1.7 .00287
a Approximate chromosomal locations ascertained from theGenetic
Location Database and the Human Genome Project Working Draft.
b Locations based on the Marshfield Map, Center for Medical
Genetics.
levels ( ), and total cholesterol levels (P ! .004 P !
), in a DZ twin sample. In addition, Lee et al..0002
(1999) detected weaker evidence of linkage (Pp
) between percentage of body fat (%BF) and.0245
D13S168 (13q14). A potential candidate gene located
at the same chromosomal region of marker D13S257
marker was described for obesity-related traits. Poly-
morphism in the 5-hydroxy-tryptamine receptor gene
(5-HTR2A [MIM 182135], located on 13q14) has been
shown to be associated with dietary energy and alcohol
intake in obese people (Aubert et al. 2000). Serotonin
(5-HT) is a key mediator in the control of satiety mech-
anisms. Serotonin reduces food intake and is probably
involved in weight regulation (Leibowitz 1990).
Despite the weaker levels of significance, tentative
linkage relationships with esterase D (MIM 133280; on
13q14) (Borecki et al. 1994) were also suggested, for
both %BF ( ) and the sum of six skin-fold mea-Pp .033
surements ( ), at approximately the same po-Pp .043
sition as our signal on chromosome 13. Thus, these
results suggest that a 5-HTR2A–linked gene may have
pleiotropic effects on BMI and on these obesity-related
traits.
Several other suggestive linkage signals with BMI were
also detected. The present suggestion for linkage on
chromosome 1q23-24 (LOD scores 1.5–1.8) is in a re-
gion containing prominent candidate genes for obesi-
ty: the sodium potassium-adenosine triphosphatase a2
(ATP1A2 [MIM 182340]) and b1 (ATP1B1 [MIM
182330]) genes. Significant association between ATP1A2
and both %BF (De´riaz et al. 1994) and respiratory quo-
tient (RQ) (De´riaz et al. 1994; Katzmarzyk et al. 1999),
as well as linkage of both ATP1A2 and ATP1B1 with
RQ (De´riaz et al. 1994; Katzmarzyk et al. 1999), were
detected in the Que´bec Family Study. RQ is associated
with energy balance and substrate use and has thus been
implicated as potentially playing a role in the develop-
ment of obesity. The ATPases are essential and ubiquitous
plasma membrane enzymes that are responsible for cat-
alyzing the energy-dependent transport of Na and K
across the cell membrane.
We also observed suggestive linkage with BMI on
chromosome 2q37 ( ), comparable to the re-Pp .0048
sults reported by Lee et al. (1999) with %BF (Pp
), indicating a possible QTL for adiposity. How-.0045
ever, no plausible candidate gene has yet been identified
in this chromosomal region.
Two recent studies have reported linkage with obe-
sity-related traits in the 3q26-27 region, near the lo-
cation (3q29) of our suggestive signal. Kissebah et al.
(2000) found strong linkage evidence on 3q26, for six
abdominal obesity- and metabolic-syndrome–related
phenotypes (LOD scores 2.37–3.54), including BMI
( ). In addition, Vionnet et al. (2000) de-Pp .00005
tected evidence for linkage with diabetes or glucose
intolerance diagnosed at age !45 years in 92 affected
sib pairs, on 3q27 ( ). This chromosomalPp .000004
region contains several potentially interesting genes,
including the genes coding for somatostatin (MIM
182450), apolipoprotein-D (apo-D [MIM 107740]), in-
hibitor 2 of the synthase-activating enzyme, type 1 pro-
tein phosphatase I-2 (MIM 601792), the bifunctional
enzyme (with enoyl-CoA-hydratase and 3-hydroxyacyl-
CoA dehydrogenase activity [MIM 261515]), glucose
transporter (MIM 138160) and the adipose-tissue–
secreted protein adiponectin (adipose most abundant
gene transcript 1 [MIM 605441]). Although these can-
didate genes each are thought to have important roles
in metabolism, signaling, and obesity-related diseases,
specific associations with adiposity have not been dem-
onstrated. The exceptions are adiponectin and apo-D.
Plasma adiponectin has been observed to be significantly
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lower in obese subjects than in nonobese subjects (Arita
et al. 1999), as well as in patients with coronary artery
disease compared with unaffected subjects matched for
age and BMI (Ouchi et al. 1999). An association be-
tween alleles of the apo-D locus and obesity has been
reported—that is, genotype frequency differences were
found between obese subjects and slim control individ-
uals, and an association was also reported between the
apo-D genotype and fasting insulin in white British
obese subjects (Vijayaraghavan et al. 1994). Evidence
of a QTL affecting cholesterol concentrations in small
LDL particles was also obtained from a genome scan
in approximately the same region as the apo-D gene
(LOD score 4.11; Rainwater et al. 1999).
Plausible candidate genes related to obesity could not
be identified in the regions 5q23 and 5q35, where we
observed suggestive evidence of linkage with BMI.
However, some studies have shown linkage in other
regions on chromosome 5q related to obesity—namely,
LIM/homeodomain islet-1 (MIM 600366, on 5q11)
(Cle´ment et al 1999), glucocorticoid receptor gene
(MIM 138040, on 5q31) (Rosmond et al. 2000), and
b2-adrenergic receptor (MIM 109690, on 5q32) (Large
et al. 1997; Ishiyama-Shigemoto et al. 1999; Meir-
haeghe et al. 1999; Yamada et al. 1999).
Corroborating evidence for linkage or the existence of
plausible obesity-related candidate genes have not been
reported in the 6q24-25 region. However, the estrogen
receptor gene (ESR1 [MIM 133430], on 6q25) maps to
this region. Lorentzon et al. (1999) observed that ESR1
was related to bone density and height during late pu-
berty in young men, and linkage (LOD score 3.85) was
found byHirschhorn et al. (2001) between amarker close
to ESR1 (6q25) and height in adults of both sexes. Fur-
thermore, Rainwater et al. (1999) reported linkage be-
tween ESR1 and LDL-3 cholesterol (LOD score 2.92, at
6q25). Although age- and sex-adjusted BMI are not cor-
related with height in the present study, a relationship
between heaviness and height, as well as between heav-
iness and lipoprotein cholesterol concentrations, are ten-
able. Thus, it would be interesting to investigate whether
ESR1 has a potential role in obesity. Likewise, there are
no previous suggestions of linkage between chromosomes
14q32 and 15q13-q14 and BMI or related phenotypes.
Further investigations should be performed to determine
whether these linkage results represent false positives or
really point to regions containing genes contributing to
obesity.
The robustness of these analyses to various factors
were certainly a concern to us. To address the question
of comparability of linkage results obtained using dif-
ferent analytic strategies, we conducted a quality control
(QC) experiment in which key linkage findings from each
of the four FHS centers were verified by an independent
investigator at another center, using their own preferred
methodology. Among the linkage approaches represented
in this exercise were SEGPATH, SOLAR, GENE-
HUNTER2, and SAGE; we focused only on quantitative
phenotypes, using the respective implementations of var-
iance-components methods available in each of the pack-
ages. It was interesting and gratifying to note that all of
thesemethods yielded comparable results, suggesting that
our reported linkage signals are not analysis-model de-
pendent. A detailed report of our QC experiment can be
found at the Family Heart Study Web site.
Two other factors potentially affecting our analyses
are (1) possible misspecification of marker allele fre-
quencies and (2) absence of an ascertainment correction.
Insofar as the former is concerned, simulation studies
and empirical analyses of real data have demonstrated
that linkage analyses of quantitative traits, particularly
those using variance-components methods, are quite ro-
bust to variations in marker-allele frequencies (Borecki
and Province 1999; Mandal et al. 2000). Perhaps the
more serious concern arises in regard to the lack of an
ascertainment correction. However, a recently published
relevant study by de Andrade and Amos (2000) showed
that the failure to correct for ascertainment in variance-
components linkage analysis affected only the estimates
of residual heritability and of environmental component
of variance and had little impact on the linked-trait gene
component of variance (and, therefore, on the linkage
inference). The greater liability may be that not cor-
recting for ascertainment can lead to a loss of power to
detect linked loci (Comuzzie and Williams 1999); thus,
it is possible that the support for the linkage hypothesis
that we see is conservative.
In conclusion, these results suggest that at least two
QTLs influence BMI in the FHS data. We obtained
strong, replicated evidence for a QTL on chromosome
7q31-q34, with leptin being a prominent candidate gene
in this region because of its central role in an adiposity-
sensing pathway and its physiological effects on energy
balance. Another region potentially harboring a QTL
was identified on chromosome 13q14, with corrobo-
rative linkage evidence from several other studies. How-
ever, additional investigation will be necessary to iden-
tify and test plausible candidate genes in this region.
Other suggestive linkage signals were found on chro-
mosomes 1q23-24, 2q37, 3q29, 5 (q23 and q35), 6q24-
25, 14q32, and 15q13-q14. Although there is indepen-
dent evidence to support the existence of some of these
putative QTLs, additional studies are necessary to rep-
licate these findings, narrow the regions, and identify
the responsible genes.
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